Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Integrates ABI's Tissue Gene-Expression Database Into MetaCore

NEW YORK (GenomeWeb News) – GeneGo has integrated Applied Biosystems’ tissue gene-expression database into its MetaCore data-mining platform, ABI said today.
 
Tatiana Nikolskaya, chief scientific officer and founder of GeneGo, said in a statement that her company has integrated the database as a tissue-expression filter in the firm’s latest product release “to replace the publicly available, but less consistent, UniGene data.”
 
She added that the companies “look forward to collaborating on additional ways to leverage our complementary solutions.”
 
ABI created the database using its expression array system and human genome survey microarray. It comprises genome-wide gene-expression values from 31 normal tissues and a universal human reference RNA.
 
ABI said the combined product “facilitates” microarray experiments, such as comparing gene-expression changes in normal, diseased, or treated human tissues.
 
Financial terms of the agreement were not disclosed.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.